Ductal Carcinoma In Situ
Showing 1 - 25 of >10,000
Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)
Recruiting
- Atypical Ductal Hyperplasia
- Ductal Carcinoma in Situ
- Vacuum-assisted excisional biopsy
-
Milan, ItalyBreast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023
Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy
Completed
- Ductal Carcinoma in Situ
- Mastectomy with sentinel lymph node biopsy
- (no location specified)
Jul 17, 2023
Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active
Completed
- Ductal Carcinoma in Situ
- Decision Support Tool with Active Monitoring
- Decision Support Tool without Active Monitoring
-
Durham, North CarolinaDuke Mammography Clinic
Jan 4, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +5 more
- Intraoperative Imaging
- Lumpectomy
-
Chicago, Illinois
- +3 more
Nov 30, 2022
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston
Completed
- Breast Atypical Ductal Hyperplasia
- +4 more
- Bexarotene
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Breast Cancer - Ductal Carcinoma in Situ (DCIS), Breast-Conserving Surgery Trial (Histolog Scanner)
Not yet recruiting
- Breast Cancer - Ductal Carcinoma in Situ (DCIS)
- Breast-Conserving Surgery
- Histolog Scanner
- (no location specified)
Jul 6, 2023
BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)
Not yet recruiting
- BRCA Mutation
- +3 more
- Tamoxifen 10 Mg Tablet
- +2 more
-
Genoa, Italy
- +3 more
Sep 11, 2023
Carcinoma, Ductal, Breast, Invasive Breast Cancer, IMAGE Trial in Seoul (contrast-enhanced breast MRI)
Completed
- Carcinoma, Ductal, Breast
- +2 more
- contrast-enhanced breast MRI
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Feb 25, 2022
MRI Characterization of Mammographically Detected DCIS
Recruiting
- Breast Cancer, Stage 0
- Breast MRI
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 21, 2022
Ductal Breast Carcinoma in Situ Trial in Stanford (Lumpectomy, Partial breast irradiation prior to surgery)
Recruiting
- Ductal Breast Carcinoma in Situ
- Lumpectomy
- Partial breast irradiation prior to surgery
-
Stanford, CaliforniaStanford University
Jan 3, 2022
Contrast-Enhanced MRI for Characterization of Ductal Carcinoma
Recruiting
- Breast Cancer
- contrast-enhanced magnetic resonance imaging
- Gadavist
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 30, 2021
Ductal Carcinoma in Situ Trial in Glendale (Cryoablation)
Recruiting
- Ductal Carcinoma in Situ
- Cryoablation
-
Glendale, CaliforniaOffice of Dennis R. Holmes, M.D., F.A.C.S.
Jan 28, 2022
Breast Cancer, Ductal Carcinoma in Situ Trial in New York (Intranasal Oxytocin)
Suspended
- Breast Cancer
- Ductal Carcinoma in Situ
- Intranasal Oxytocin
-
New York, New YorkColumbia University Medical Center
Jul 28, 2022
Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in
Recruiting
- DCIS
-
Victoria, British Columbia, Canada
- +9 more
Jan 31, 2023
Breast Cancer, Ductal Carcinoma in Situ Trial in Basking Ridge, Commack, New York (MRI)
Active, not recruiting
- Breast Cancer
- Ductal Carcinoma in Situ
- MRI
-
Basking Ridge, New Jersey
- +2 more
Nov 7, 2022
DCIS Trial (Delay sentinel node biopsy)
Not yet recruiting
- DCIS
- Delay sentinel node biopsy
- (no location specified)
Jun 12, 2023
Standard Breast Cancer Risk Assessment for African American and
Not yet recruiting
- Breast Atypical Ductal Hyperplasia
- +3 more
- Biospecimen Collection
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 22, 2023
Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,
Active, not recruiting
- Deleterious BRCA1 Gene Mutation
- +5 more
- Behavioral, Psychological or Informational Intervention
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Ductal Carcinoma in Situ, Invasive Ductal Carcinoma of Female Breast Trial in Stuart, Tampa (stereotactic body radiation
Recruiting
- Ductal Carcinoma in Situ
- Invasive Ductal Carcinoma of Female Breast
- stereotactic body radiation therapy
-
Stuart, Florida
- +1 more
Aug 3, 2022
Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated
Recruiting
- Ductal Breast Carcinoma in Situ
- +6 more
- Hypofractionated radiotherapy
-
Mérida, Yucatán, MexicoUnidad Medica de Alta Especialidad
Nov 7, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +4 more
-
Houston, Texas
- +2 more
Aug 17, 2022
Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma Trial in Duarte (Agent Affecting Integumentary System,
Recruiting
- Breast Ductal Carcinoma In Situ
- Invasive Breast Carcinoma
- Agent Affecting Integumentary System
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 30, 2022
Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT
Not yet recruiting
- Breast Cancer
- +2 more
- LS301-IT 0.025 mg/kg
- +3 more
-
Scottsdale, ArizonaIntegro Theranostics Research Site #1
Jun 2, 2023